filmov
tv
Drugging an undruggable pocket on KRAS
Показать описание
Darryl B McConnell
KRAS
cancer
chemistry
Рекомендации по теме
0:01:25
Drugging an undruggable pocket on KRAS
0:03:33
Drugging the 'Undruggable' K-Ras Oncogene | Kevan Shokat
0:02:29
Drugging the undruggable: a marketreadiness analysis for KRAS-G12C
0:46:57
Drugging the undruggable with protein interference | Benedict Cross
0:08:28
Koehler - Drugging an Undruggable Target
0:01:30
Drugging the undruggable with molecular glues (Petzold & Gainza et al, Biorxiv 2024)
0:04:30
Drugging the Elusive KRAS
0:01:21
KRAS Binders Hidden in Nature
0:59:51
Drugging the Undruggable: Targeted Protein Degradation as Medicine - 5 April 2022
0:42:13
Overcoming the undruggable nature of the most common human oncogene K-Ras
1:01:44
Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras
0:01:14
KRAS mutation: from undruggable to druggable in cancer | RTCL.TV
0:17:44
5.5 Drugable or undrugable targets
0:01:32
New strategy for targeting cancer causing protein previously considered “undruggable”
0:01:01
Alnylam Targets “Undruggable” Diseases
0:04:09
A New Era in Targeting KRAS
0:00:39
RAS‐targeted cancer therapy: Advances in drugging specific mutations | RTCL.TV
0:39:24
Druggability and the druggable genome
0:45:21
RAS Oncoproteins Therapeutic Vulnerabilities
0:02:15
Sotorasib drug-drug interactions
0:57:01
Von Hippel-Lindau Disease: Insights into Oxygen Sensing, Cancer and Drugging the Undruggable
0:31:44
Innovative Approaches to Investigating KRAS Therapeutics with Biochemical and Cell Based Assays 2
0:49:44
William Kaelin | Max Birnstiel Lecture
0:01:11
What is a KRAS mutation?
welcome to shbcf.ru
0:01:25
0:03:33
0:02:29
0:46:57
0:08:28
0:01:30
0:04:30
0:01:21
0:59:51
0:42:13
1:01:44
0:01:14
0:17:44
0:01:32
0:01:01
0:04:09
0:00:39
0:39:24
0:45:21
0:02:15
0:57:01
0:31:44
0:49:44
0:01:11